Bioarray Genetics (formerly known as Bioarray Therapeutics) is a biotechnology company that develops predictive diagnostic tests for cancer treatment. The Company develops proprietary predictive diagnostic tests, based on cancer genes (markers), to choose to the most efficacious treatment for cancer patients beforehand, rather than the trial and error approach currently used.